NYSE - Delayed Quote USD

Cencora, Inc. (COR)

221.94 -0.98 (-0.44%)
At close: May 14 at 4:00 PM EDT
221.06 -0.88 (-0.40%)
After hours: May 14 at 5:25 PM EDT
Loading Chart for COR
DELL
  • Previous Close 222.92
  • Open 223.18
  • Bid 136.30 x 1000
  • Ask 227.39 x 800
  • Day's Range 220.68 - 223.71
  • 52 Week Range 163.37 - 246.75
  • Volume 1,341,421
  • Avg. Volume 1,237,949
  • Market Cap (intraday) 44.266B
  • Beta (5Y Monthly) 0.47
  • PE Ratio (TTM) 24.28
  • EPS (TTM) 9.14
  • Earnings Date Jul 31, 2024 - Aug 5, 2024
  • Forward Dividend & Yield 2.04 (0.92%)
  • Ex-Dividend Date May 9, 2024
  • 1y Target Est 258.07

Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

www.cencora.com

46,000

Full Time Employees

September 30

Fiscal Year Ends

Recent News: COR

Performance Overview: COR

Trailing total returns as of 5/14/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

COR
8.30%
S&P 500
10.00%

1-Year Return

COR
30.76%
S&P 500
27.22%

3-Year Return

COR
92.75%
S&P 500
27.58%

5-Year Return

COR
215.50%
S&P 500
86.59%

Compare To: COR

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: COR

Valuation Measures

Annual
As of 5/13/2024
  • Market Cap

    44.46B

  • Enterprise Value

    47.64B

  • Trailing P/E

    24.39

  • Forward P/E

    16.72

  • PEG Ratio (5yr expected)

    2.02

  • Price/Sales (ttm)

    0.16

  • Price/Book (mrq)

    41.05

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.67%

  • Return on Assets (ttm)

    2.88%

  • Return on Equity (ttm)

    213.15%

  • Revenue (ttm)

    276.54B

  • Net Income Avi to Common (ttm)

    1.85B

  • Diluted EPS (ttm)

    9.14

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.07B

  • Total Debt/Equity (mrq)

    543.70%

  • Levered Free Cash Flow (ttm)

    2.68B

Research Analysis: COR

Company Insights: COR

Research Reports: COR

People Also Watch